1 Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, USA. Electronic address: bbikdeli@bwh.harvard.edu.
2 Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
3 Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
4 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA; Virginia Commonwealth University, Richmond, Virginia, USA.
5 Harvard Medical School, Boston, Massachusetts, USA.
6 Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
7 Te Whatu Ora Te Toka Tumai Auckland, Auckland, New Zealand.
8 Université Paris-Cité, INSERM U1148, FACT French Alliance for Cardiovascular Trials, AP-HP Hopital Bichat, Paris, France.
9 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
10 Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA; St Francis Hospital and Heart Center, Roslyn, New York, USA.
11 St Francis Hospital and Heart Center, Roslyn, New York, USA; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
12 Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, USA; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, USA.